Study to Assess Safety and Tolerability of AZD4547 in Japanese Patient
NCT01213160
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Cancer
Advanced Solid Malignancies
Interventions
DRUG:
AZD4547
Sponsor
AstraZeneca